Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiaohuopu Tuire Mixture
- Development stage
- Unknown
- Lead developer
- Hospital of Chengdu University of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yinqiaohuopu Tuire Mixture (also known as Xinguan No. 2) is a traditional Chinese medicine (TCM) hospital preparation developed by the Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Provincial Hospital of Traditional Chinese Medicine) for the treatment of COVID-19. It is formulated based on the modification of Yinqiao San and Huopu Xialing Tang, specifically targeting the 'wind-heat with dampness' syndrome (风热夹湿证) of respiratory infections. During the COVID-19 outbreak in early 2020, it was approved under emergency procedures by the Sichuan Provincial Medical Products Administration and the Sichuan Administration of Traditional Chinese Medicine for use across designated COVID-19 treatment hospitals in Sichuan Province.
- Other names
- Yinqiao Huopu Tuire HejiYinqiao Huopu Tuire MixtureYinqiaohuopu Tuire Heji银翘藿朴退热合剂
Beyond the preview
Go deeper on Yinqiaohuopu Tuire Mixture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinqiaohuopu Tuire Mixture.